SRC and breast carcinoma: HDAC2 enables the motility of breast cancer cells by upregulating Matrix Metalloproteinase 2 (MMP2) and N-cadherin and HDAC3 associates with Epidermal Growth Factor Receptor (EGFR) and c-Src to promote breast cancer cell invasion [89,90].